COVID-19 Deaths May Not Do Much to Life Insurers’ Earnings: Securities Analyst
March 31, 2020 by Allison Bell
Even now, it looks as if the number of U.S. deaths caused by COVID-19 may not be big enough to do much to the typical publicly traded U.S. life and annuity issuer’s 2020 earnings.
Ryan Krueger, a securities analyst at Keefe, Bruyette & Woods Inc., makes that case in a new analysis of COVID-19 mortality scenarios.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the COVID-19 disease, can kill people by causing pneumonia, heart inflammation and kidney failure.
The U.S. Centers for Disease Control and Prevention reported Monday that it had recorded 140,904 cases of COVID-19 that were confirmed by state, municipal or federal testing laboratories, and 2,405 COVID-19-related deaths.
Click HERE to read the full story via ThinkAdvisor
